BCM
PFE icon

Bourgeon Capital Management’s Pfizer PFE Stock Holding History

Bourgeon Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.98M Buy
372,849
+17,682
+5% +$463K 1.32% 35
2026
Q1 		$9.97M Buy
355,167
+341,896
+2,576% +$9.1M 1.73% 26
2025
Q4 		$330K Buy
+13,271
New +$335K 0.05% 107
2025
Q3 		– Sell
-213,288
Closed -$5.17M – 116
2025
Q2 		$5.17M Sell
213,288
-200,406
-48% -$4.67M 1.02% 38
2025
Q1 		$10.5M Sell
413,694
-4,964
-1% -$130K 2.26% 17
2024
Q4 		$11.1M Buy
418,658
+359,721
+610% +$9.76M 2.07% 17
2024
Q3 		$1.71M Buy
58,937
+7,498
+15% +$219K 0.33% 55
2024
Q2 		$1.44M Sell
51,439
-14,433
-22% -$397K 0.28% 61
2024
Q1 		$1.83M Buy
65,872
+18,794
+40% +$522K 0.36% 57
2023
Q4 		$1.36M Sell
47,078
-7,449
-14% -$225K 0.3% 57
2023
Q3 		$1.81M Sell
54,527
-2,998
-5% -$106K 0.42% 55
2023
Q2 		$2.11M Buy
57,525
+37,201
+183% +$1.45M 0.49% 49
2023
Q1 		$829K Buy
20,324
+2
+0% +$86 0.2% 61
2022
Q4 		$1.04M Sell
20,322
-5,720
-22% -$274K 0.26% 55
2022
Q3 		$1.14M Buy
26,042
+12,501
+92% +$607K 0.31% 52
2022
Q2 		$710K Buy
13,541
+3,001
+28% +$153K 0.19% 66
2022
Q1 		$546K Buy
10,540
+388
+4% +$20.1K 0.12% 71
2021
Q4 		$599K Sell
10,152
-260
-2% -$12.9K 0.12% 72
2021
Q3 		$448K Sell
10,412
-17,000
-62% -$753K 0.1% 80
2021
Q2 		$1.07M Sell
27,412
-29,240
-52% -$1.14M 0.23% 64
2021
Q1 		$2.05M Buy
56,652
+40,000
+240% +$1.42M 0.46% 51
2020
Q4 		$613K Buy
16,652
+15,708
+1,664% +$576K 0.15% 73
2020
Q3 		$33K Hold
944
– – 0.01% 161
2020
Q2 		$29K Hold
944
– – 0.01% 141
2020
Q1 		$29K Hold
944
– – 0.02% 130
2019
Q4 		$35K Hold
944
– – 0.02% 126
2019
Q3 		$32K Buy
+944
New +$34.3K 0.02% 129

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bourgeon Capital Management's PFE Position: Q2 2026 in Review

Bourgeon Capital Management increased its Pfizer (PFE) stake by 5% in Q2 2026, buying an estimated $463K and bringing the position to 372,849 shares worth $8.98M. The position accounts for 1.32% of the portfolio, ranked #35.

Bourgeon Capital Management first reported a position in PFE in Q3 2019 and has held it in 27 quarters since. The position peaked at $11.1M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bourgeon Capital Management held 372,849 shares of Pfizer worth $8.98M as of Q2 2026.
  • Bourgeon Capital Management bought 17,682 Pfizer shares in Q2 2026, an estimated $463K.
  • Pfizer made up 1.32% of Bourgeon Capital Management's portfolio in Q2 2026, its #35 holding.
  • Bourgeon Capital Management first reported a position in Pfizer in Q3 2019 and has held it in 27 quarters since.
  • Bourgeon Capital Management's Pfizer position peaked at $11.1M in Q4 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bourgeon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.